Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on April 10, 2025

Bridger Aerospace Awarded Exclusive-Use Contract by State of Montana for Innovative Wildfire Detection Aircraft

Bridger Aerospace Awarded Exclusive-Use Contract by State of Montana for Innovative Wildfire Detection Aircraft

BELGRADE, Mont., April 10, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”) (NASDAQ: BAER, BAERW), announced today that, after participating in a competitive bidding process, it has been notified by the …

Evaxion to present at World Vaccine Congress

Evaxion to present at World Vaccine Congress

Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will give two …

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …

STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base

STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base

PR No: C3330C STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base Increasing efficiency, automation, and AI will strengthen ST’s key technology R…

Eviden signs a 50-million-euro contract to build Serbia’s National AI Factory

Eviden signs a 50-million-euro contract to build Serbia’s National AI Factory

Eviden will bring together a unique comprehensive set of AI capabilities – supercomputing power for AI, software layer and AI use-cases development Paris, France – April 10, 2025 – Eviden, the Atos Group business leading in digital, cloud, big data and …

STMicroelectronics détaille son projet d’entreprise de remodelage de son empreinte industrielle et de redimensionnement de sa base de coûts globale

STMicroelectronics détaille son projet d’entreprise de remodelage de son empreinte industrielle et de redimensionnement de sa base de coûts globale

PR No: C3330C STMicroelectronics détaille son projet d’entreprise de remodelage de son empreinte industrielle et de redimensionnement de sa base de coûts globale Efficacité accrue, automatisation et IA renforceront les actifs clés de ST en termes de R…

Eviden signe un contrat de 50 millions d'euros pour développer une « AI Factory » nationale en Serbie

Eviden signe un contrat de 50 millions d'euros pour développer une « AI Factory » nationale en Serbie

Eviden fournira un ensemble complet et unique de capacités d'IA associant puissance de supercalcul, couche logicielle et développement de cas d’usage d’IA Paris, France – 10 avril 2025 – Eviden, la ligne d’activités du groupe Atos leader dans le digital, …

Advanced PMIC for High-Performance AI, Industrial Computing and Data Center Applications

Advanced PMIC for High-Performance AI, Industrial Computing and Data Center Applications

CHANDLER, Ariz., April 10, 2025 (GLOBE NEWSWIRE) -- The rapid integration of AI into industrial, computing and data center applications is fueling a growing demand for more efficient and advanced power management solutions. Microchip Technology (Nasdaq: …

Vertex baut sein Chief Strategy Office aus, um e-Invoicing und globale Compliance-Initiativen voranzutreiben

Vertex baut sein Chief Strategy Office aus, um e-Invoicing und globale Compliance-Initiativen voranzutreiben

KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX), ein globaler Anbieter von Technologielösungen für indirekte Steuern, gab heute die Erweiterung seines Chief Strategy Office (CSO) bekannt: Christopher Hall und Kathya …

Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives

Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives

KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced the expansion of its Chief Strategy Office (CSO) with the addition of …

Avalyn to Participate in Upcoming Investor Conference in April

Avalyn to Participate in Upcoming Investor Conference in April

CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will …

Global Clean Technology Innovators Honored in 2025 CleanTech Breakthrough Awards Program

Global Clean Technology Innovators Honored in 2025 CleanTech Breakthrough Awards Program

LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- CleanTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout climate and clean technology companies, products and services around the globe, today …

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …

NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET

NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET

HOLLYWOOD, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of tech-enabled engineering, certification, and consulting solutions, will announce its financial results for the first quarter ended …

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need …

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis

– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a patient survey conducted in partnership with the National …

Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases

Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases

Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes …

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …

Byrna Technologies Fiscal First Quarter 2025 Results

Byrna Technologies Fiscal First Quarter 2025 Results

ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

FREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has been …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service